title: Transposon insertions in the Flavobacterium johnsoniae ftsX gene disrupt gliding motility and cell division.
abstract: Flavobacterium johnsoniae is a gram-negative bacterium that exhibits gliding motility. To determine the mechanism of flavobacterial gliding motility, we isolated 33 nongliding mutants by Tn4351 mutagenesis. Seventeen of these mutants exhibited filamentous cell morphology. The region of DNA surrounding the transposon insertion in the filamentous mutant CJ101-207 was cloned and sequenced. The transposon was inserted in a gene that was similar to Escherichia coli ftsX. Two of the remaining 16 filamentous mutants also carried insertions in ftsX. Introduction of the wild-type F. johnsoniae ftsX gene restored motility and normal cell morphology to each of the three ftsX mutants. CJ101-207 appears to be blocked at a late stage of cell division, since the filaments produced cross walls but cells failed to separate. In E. coli, FtsX is thought to function with FtsE in translocating proteins involved in potassium transport, and perhaps proteins involved in cell division, into the cytoplasmic membrane. Mutations in F. johnsoniae ftsX may prevent translocation of proteins involved in cell division and proteins involved in gliding motility into the cytoplasmic membrane, thus resulting in defects in both processes. Alternatively, the loss of gliding motility may be an indirect result of the defect in cell division. The inability to complete cell division may alter the cell architecture and disrupt gliding motility by preventing the synthesis, assembly, or functioning of the motility apparatus.
authors.affiliation: Department of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Kempf
authors.forename: M J
authors.initials: MJ
authors.lastname: McBride
mesh_terms: D000595:Amino Acid Sequence; D001419:Bacteria / Q000187:drug effects / Q000235:genetics / Q000648:ultrastructure; D018407:Bacterial Physiological Phenomena; D001426:Bacterial Proteins; D001435:Bacteriophages / Q000502:physiology; D018797:Cell Cycle Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D002455:Cell Division / Q000235:genetics / Q000502:physiology*; D002506:Cephalexin / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D003001:Cloning, Molecular; D004251:DNA Transposable Elements; D029968:Escherichia coli Proteins; D005417:Flavobacterium / Q000187:drug effects / Q000235:genetics / Q000502:physiology* / Q000648:ultrastructure; D005816:Genetic Complementation Test; D008854:Microscopy, Electron; D018715:Microscopy, Video; D008863:Microspheres; D008969:Molecular Sequence Data; D009068:Movement; D016254:Mutagenesis, Insertional; D011189:Potassium Chloride / Q000494:pharmacology; D017422:Sequence Analysis, DNA; D012965:Sodium Chloride / Q000494:pharmacology
chemical_list: D001426:Bacterial Proteins; D018797:Cell Cycle Proteins; D002511:Cephalosporins; D004251:DNA Transposable Elements; D029968:Escherichia coli Proteins; C491157:FtsX protein, E coli; C102286:FtsX protein, bacteria; D012965:Sodium Chloride; D011189:Potassium Chloride; D002506:Cephalexin